Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Carlos Kamiya"'
Publikováno v:
Current Oncology, Vol 30, Iss 6, Pp 5279-5298 (2023)
Establishing novel therapies for rare central nervous system (CNS) tumors is arduous due to challenges in conducting clinical trials in rare tumors. Immunotherapy treatment has been a rapidly developing field and has demonstrated improvements in outc
Externí odkaz:
https://doaj.org/article/5b3ffda32b984ff381bedc6892b0f53e
Autor:
John de Groot, Martina Ott, Jun Wei, Cynthia Kassab, Dexing Fang, Hinda Najem, Barbara O'Brien, Shiao-Pei Weathers, Carlos Kamiya Matsouka, Nazanin K Majd, Rebecca A Harrison, Gregory N Fuller, Jason T Huse, James P Long, Raymond Sawaya, Ganesh Rao, Tobey J MacDonald, Waldemar Priebe, Michael DeCuypere, Amy B Heimberger
Publikováno v:
CNS Oncology, Vol 11, Iss 02 (2022)
Aim: To ascertain the maximum tolerated dose (MTD)/maximum feasible dose (MFD) of WP1066 and p-STAT3 target engagement within recurrent glioblastoma (GBM) patients. Patients & methods: In a first-in-human open-label, single-center, single-arm 3 + 3 d
Externí odkaz:
https://doaj.org/article/f172809d74d443f2aaf6cc04d8836b6d
Autor:
Ahmad Daher, Carlos Kamiya Matsuoka, Monica Elena Loghin, Marta Penas-Prado, Sudhakar Tummala
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 93-100 (2019)
Immune checkpoint inhibitors (CPIs) (anti-cytotoxic T-lymphocyte antigen-4, anti-programmed death 1, and anti-programmed death-ligand 1) have transformed the landscape of cancer therapy. However, their increasing use has unleashed immune-related adve
Externí odkaz:
https://doaj.org/article/40869ad339224f7d812f2a85f6723c42
Autor:
Aung Naing, Filip Janku, Mingxuan Xu, Anas Alshawa, Nazanin Majd, Steven G Waguespack, Marta Penas-Prado, Carlos Kamiya-Matsuoka, Shaan M Raza, Ian E McCutcheon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Pituitary carcinoma is an aggressive tumor characterized by metastatic spread beyond the sellar region. Symptoms can be debilitating due to hormonal excess and survival is poor. Pituitary carcinomas recur despite conventional multimodality treatments
Externí odkaz:
https://doaj.org/article/e142b33dba1045f1b1ac27cad95671c1
Publikováno v:
Anales de la Facultad de Medicina, Vol 71, Iss 1, Pp 37-42 (2010)
Introducción: Una de las más serias amenazas que enfrentan los estudiantes de medicina durante su práctica clínica es la posibilidad de exposición a accidentes biológicos, debido en la mayoría de los casos a la inexperiencia y el escaso desarr
Externí odkaz:
https://doaj.org/article/8358ead458924a059538f019e27903b3
Autor:
Kaysia Ludford, Won Jin Ho, Jane V. Thomas, Kanwal P.S. Raghav, Mariela Blum Murphy, Nicole D. Fleming, Michael S. Lee, Brandon G. Smaglo, Y. Nancy You, Matthew M. Tillman, Carlos Kamiya-Matsuoka, Selvi Thirumurthi, Craig Messick, Benny Johnson, Eduardo Vilar, Arvind Dasari, Sarah Shin, Alexei Hernandez, Xuan Yuan, Hongqui Yang, Wai Chin Foo, Wei Qiao, Dipen Maru, Scott Kopetz, Michael J. Overman
Publikováno v:
Journal of Clinical Oncology. 41:2181-2190
PURPOSE Pembrolizumab significantly improves clinical outcomes in advanced/metastatic microsatellite instability high (MSI-H)/deficient mismatch repair (dMMR) solid tumors but is not well studied in the neoadjuvant space. METHODS This is a phase II o
Autor:
Franco Rubino, Solon Schur, Susan L. McGovern, Carlos Kamiya-Matsuoka, Franco DeMonte, Shaan M. Raza
Publikováno v:
Journal of Neurosurgery. :1-12
OBJECTIVE Long-term follow-up of meningiomas has demonstrated recurrence rates ranging from 2.5% to 48% after 10 years, depending on histology grade. There are limited data available to guide the management of recurrent and previously irradiated skul
Autor:
Timothy A. Yap, Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M. Kantarjian, Farhad Ravandi, Meghan E. Collins, Maria Emilia Di Francesco, Ecaterina E. Dumbrava, Siqing Fu, Sisi Gao, Jason P. Gay, Sonal Gera, Jing Han, David S. Hong, Elias J. Jabbour, Zhenlin Ju, Daniel D. Karp, Alessia Lodi, Jennifer R. Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A. Piha-Paul, Jordi Rodon, Carolina Salguero, Koji Sasaki, Anand K. Singh, Vivek Subbiah, Apostolia M. Tsimberidou, Quanyun A. Xu, Musa Yilmaz, Qi Zhang, Yuan Li, Christopher A. Bristow, Meenakshi B. Bhattacharjee, Stefano Tiziani, Timothy P. Heffernan, Christopher P. Vellano, Philip Jones, Cobi J. Heijnen, Annemieke Kavelaars, Joseph R. Marszalek, Marina Konopleva
Publikováno v:
Nature Medicine. 29:115-126
Autor:
Amy B. Heimberger, Katayoun Rezvani, Elizabeth J. Shpall, Raymond Sawaya, Frederick F. Lang, Jeffrey S. Weinberg, Ganesh Rao, Linda Chi, Jason T. Huse, Gregory N. Fuller, Carlos Kamiya-Matsuoka, Nazanin Majd, Rebecca Harrison, Barbara J. O'Brien, John F. de Groot, Mayra Shanley, Abdullah Alsuliman, Hila Shaim, Mustafa Bdiwi, Pinaki Banerjee, Cynthia Kassab, Xiaoyang Ling, Be-Lian Pei, Marta Penas-Prado, Shiao-Pei Weathers
Supplementary Figure 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed3b580f8c8ad31fe8333f566ca434e
https://doi.org/10.1158/1078-0432.22475456
https://doi.org/10.1158/1078-0432.22475456
Autor:
Amy B. Heimberger, Katayoun Rezvani, Elizabeth J. Shpall, Raymond Sawaya, Frederick F. Lang, Jeffrey S. Weinberg, Ganesh Rao, Linda Chi, Jason T. Huse, Gregory N. Fuller, Carlos Kamiya-Matsuoka, Nazanin Majd, Rebecca Harrison, Barbara J. O'Brien, John F. de Groot, Mayra Shanley, Abdullah Alsuliman, Hila Shaim, Mustafa Bdiwi, Pinaki Banerjee, Cynthia Kassab, Xiaoyang Ling, Be-Lian Pei, Marta Penas-Prado, Shiao-Pei Weathers
Supplementary Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5816b2ac16537ecc0476ebdfde4ba5
https://doi.org/10.1158/1078-0432.22475459.v1
https://doi.org/10.1158/1078-0432.22475459.v1